The Experts in Animal Health

print version

Brakke Consulting’s
Animal Health News & Notes for April 17, 2015

Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon DVM MBA
Brakke Consulting news
Pain Management Products report – NOW AVAILABLE
OTC Channel
earnings news
other news
Animal Supply Company
Coast Pet Distributors
Epica Medical Innovations
Henry Schein
Jack’s Pets
Natural American Pet Products
Natural Life Pet Products
Oculus Innovative Sciences
Pet Valu
The Prescription Center

Pain management is one of the leading topics in veterinary medicine today. Brakke Consulting’s annual report on Pain Management Products for Dogs and Cats includes such valuable information as:
– overview of acute and chronic pain in small animals
– review of new products
– estimates of US sales and prices of leading products
– pain management products in development
– review of nutritional supplements used for chronic pain
– review of therapeutic diets for joint care
– 2015 survey of 223 small animal veterinarians regarding use of pain management products

Pain Management Products for Dogs and Cats 2015 can be purchased for immediate shipping for $5,500. For information, contact Lynn Fondon, DVM, MBA at 972-243-4033, or email . 
> Virbac reported financial results for the first quarter of 2015. Sales totaled EUR 211 million ($227 million), an increase of 17% compared to the prior year comparable quarter. The firm attributed its year-on-year growth to a positive change in exchange rates and its acquisition of the Sentinel range of antiparasitics for dogs. (Animal Pharm)
> Vetoquinol reported financial results for the first quarter of 2015. Sales totaled EUR 81 million ($87 million) in the first quarter, an increase of 11% compared to the first quarter of 2014. Sales growth at a constant exchange rate in first quarter was 5%. (Animal Pharm)
> Nestle S.A. reported financial results for the first quarter of 2015. Petcare sales were CHF 2,756 million ($2,858 million), an increase of 2% compared to the first quarter of 2014. (company press release)
> Cargill reported results for its fiscal 2015 third quarter ended Feb. 28, 2015. Revenues in the third quarter decreased 11% to $28.4 billion; net earnings were $425 million, a 33% increase compared to the year-ago period. The Animal Nutrition and Protein segment made the largest contribution to Cargill’s third-quarter earnings. (Watt Agnet)

The KC Animal Health Corridor is now accepting applications to present at the 2015 KC Animal Health Investment Forum on September 1 in Kansas City, Missouri.

Now in its seventh year, the Forum is one of the only opportunities in the world for early-stage companies in the animal health sector to present their vision, business plan and technology to potential investors.

The selection committee will consider companies that meet the following criteria:
– Seeking $500,000 – $20 million in funding
– Revenue projections of $20 million within 5-7 years

Applications are due on April 17. To apply, go to For more information, contact Kimberly Young at
> Hill’s announced the launch of Prescription Diet c/d Multicare Canine. Multicare Canine dissolves struvite stones, reduces the risk of oxalate and struvite stones, and reduces inflammation from urinary tract infections and stones. (company announcement) 
> VetDC announced it has secured $2.1 million in its latest round of funding; the company anticipates that the full round of funding will amount to $3 – $6 million. The funds will be used to bring its Tanovea canine lymphoma drug to the US market. (Animal Pharm) 
> Innovacyn announced the launch of Vetericyn Plus for dairy and beef cattle. Vetericyn Plus is a product line of innovative solutions indicated for wounds, pink eye, udder ailments and teat irritations that includes a higher concentration of hypochlorous, making it up to three times as concentrated as original Vetericyn without requiring any withdrawal period. (PRWeb) 
> Oculus Innovative Sciences, Inc. announced the introduction of MicrocynAH Farm and Ranch Spray and MicrocynAH Farm and Ranch Hydrogel. Oculus has partnered with SLA Brands to bring the MicrocynAH products, including the new farm and ranch offerings, to market. ( 
> Epica Medical Innovations announced that Henry Schein Animal Health will be the exclusive distributor of its products to veterinarians throughout the US. Henry Schein will offer its customers Epica’s Vimago, a high-definition, robotically controlled CT Scanner, Fluoroscopy and Digital X-ray unit and Artemis, a therapeutic device that can eliminate inflammation and regenerate tissue non-invasively. (PRWeb) 
> Pet Valu announced the acquisition of Jack’s Pets as well as its online outlet Financial terms were not disclosed. (Pet Business) 
> Animal Supply Company has acquired the assets of Coast Pet Distributors headquartered in California. Coast will operate as part of the ASC West Region and immediately begin serving customers as Animal Supply Company. Financial terms were not disclosed. ( 
> Dogswell, LLC, announced that it has acquired Natural American Pet Products and Natural Life Pet Products, adding vertical integration in the premium, high-quality pet treat space. Financial terms were not disclosed. ( 
> The FDA and the North Carolina Board of Pharmacy (NC BOP) announced that The Prescription Center compounding pharmacy has been closed by order of the NC BOP, and the NC BOP has ordered a recall of all lots of sterile and non-sterile products compounded or repackaged and distributed by the Prescription Center between Sept. 10, 2014, and March 10, 2015. In an inspection conducted in March by the NC BOP, state inspectors observed significant deficiencies that raise concerns about the company’s ability to assure the sterility, stability and potency of the sterile and non-sterile human and veterinary drug products that it produced. (FDA) 
> US – CANINE INFLUENZA  Cornell University reported that states that the ongoing canine influenza in the Chicago area is due to the H3N2 subtype of canine influenza, not the H3N8 subtype that has been seen in the US previously. This is the first identification of the H3N2 subtype outside of Asia. At this time, it is not known if the currently available H3N8 vaccines will provide any cross-immunity to dogs exposed to the H3N2 subtype. (AVMA)
> US – AVIAN INFLUENZA  The USDA confirmed the first case of H5N2 influenza in a commercial chicken flock in Wisconsin, widening the impact of a virus that has already killed hundreds of thousands of turkeys this year. State officials quarantined the premises and birds there will be culled to prevent the spread of the disease. (
> WORLD – KETAMINE CLASSIFICATION  The World Veterinary Association (WVA) is opposing further discussion by United Nations’ agencies to have the anesthetic ketamine classed as a narcotic and banned globally. The WVA strongly objects to re-classification of ketamine as this could lead to it no longer being available to veterinary and medical clinicians, especially in remote areas. The WVA said that ketamine is an important drug for anesthesia in veterinary medicine. It is used for routine veterinary medical interventions and sometimes to restrain dangerous animals. (Animal Pharm)
> US – IV FLUID SHORTAGE The FDA’s Center for Veterinary Medicine is coordinating with drug companies to increase the availability of three- to five-liter intravenous (IV) fluids intended to provide large animals with IV fluid replacement therapy. The current shortage has been triggered by several factors. To address the immediate need, the FDA will temporarily exercise enforcement discretion over the importation of large volume IV solutions that are currently marketed in foreign countries and carry labeling appropriate for those countries. Several companies are currently preparing to import five-liter fluids into the US. (FDA)
> US – ANTIMICROBIAL USE REPORT   The FDA published its fifth annual report summarizing the sales and distribution data of antimicrobial drugs approved for use in food-producing animals. The 2013 Annual Report can be found at  (FDA)

Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting’s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution. If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact our Dallas office or Joel Adamson at
The first two larger companies to report first quarter 2015 results have some reasonable growth versus prior year. The financial analysts’ calculators are going to be kept busy understanding company revenues and profits that will need to be adjusted for mergers, divestitures and exchange rates in many of the leading companies. We are hearing from other firms in the industry that the first quarter will be positive, which will be three quarters in a row of nice revenue growth.

I’ve had an interesting and productive week in Japan. Thanks to all of the managers that attended our annual animal health overview in Tokyo and participated in various one-on-one meetings. Japan is one of those developed animal health and pet markets that is undergoing transformational changes. It is interesting to observe that many of the issues in the Japanese market are similar to the US and Western Europe industry issues. However, new technology is alive and well here in Japan, thanks to a longer-term view taken by some of the leading research companies. Several of those new technologies will be heading to the animal health and pet market near you in the future.

Have a great weekend!!
Ron Brakke
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services and syndicated studies, visit our website at
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX  75234    USA


en_USEnglish (United States)